PRA Health Sciences, Inc

(NASDAQ:PRAH)

Latest On PRA Health Sciences, Inc (PRAH):

Date/Time Type Description Signal Details
2020-04-09 05:24 ESTAnalyst RatingThe Analyst Target Price has decreased from $109.23 to $107.77.Neutral
2020-04-07 09:28 ESTAnalyst RatingThe Analyst Target Price has decreased from $110.23 to $109.23.Neutral
2020-04-03 21:32 ESTFinancialsCompany financials have been released.Neutral
2020-03-31 05:19 ESTAnalyst RatingThe Analyst Target Price has decreased from $113.23 to $110.23.Neutral
2020-03-29 01:13 ESTAnalyst RatingThe Analyst Target Price has decreased from $113.92 to $113.23.Neutral
2020-03-24 21:20 ESTAnalyst RatingThe Analyst Target Price has decreased from $116.69 to $113.92.Neutral
2020-03-18 05:21 ESTAnalyst RatingThe Analyst Target Price has decreased from $119.62 to $116.69.Neutral
2020-03-16 05:20 ESTAnalyst RatingThe Analyst Target Price has decreased from $120 to $119.62.Neutral
2020-03-13 05:22 ESTAnalyst RatingThe Analyst Target Price has decreased from $121.38 to $120.Neutral
2020-03-06 04:17 ESTAnalyst RatingThe Analyst Target Price has decreased from $121.54 to $121.38.Neutral
2020-02-29 00:31 ESTAnalyst RatingThe Analyst Target Price has increased from $120.85 to $121.54.Buy
2020-02-28 04:46 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 22:13 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 22:13 ESTEarnings EstimateAn EPS average of $6.56 is estimated for the 2021 year.Buy
2020-02-27 22:13 ESTEarnings EstimateAn EPS average of $1.43 is estimated for the quarter ending on June 30, 2020.Sell
2020-02-27 22:13 ESTEarningsEarnings have been released on February 20, 2020, with $1.54 earnings per share.Buy
2020-02-27 22:13 ESTAnalyst RatingThe Analyst Target Price has increased from $120.69 to $120.85.Buy
2020-02-22 00:29 ESTFinancialsCompany financials have been released.Neutral
2020-02-21 23:12 ESTNewsPRA Health Sciences, Inc. 2019 Q4 - Results - Earnings Call PresentationN/A
2020-02-21 23:12 ESTNewsPRA Health Sciences, Inc. (PRAH) CEO Colin Shannon on Q4 2019 Results - Earnings Call TranscriptN/A
2020-02-18 00:15 ESTFinancialsCompany financials have been released.Neutral
2020-02-13 00:29 ESTFinancialsCompany financials have been released.Neutral
2020-02-07 00:35 ESTFinancialsCompany financials have been released.Neutral
2020-02-01 00:31 ESTFinancialsCompany financials have been released.Neutral
2020-01-29 00:28 ESTFinancialsCompany financials have been released.Neutral
2020-01-28 04:48 ESTEarningsEarnings have been released on October 31, 2019, with $1.25 earnings per share.Sell
2020-01-28 00:33 ESTFinancialsCompany financials have been released.Neutral
2020-01-28 00:33 ESTAnalyst RatingThe Analyst Target Price has increased from $119.69 to $120.69.Buy
2020-01-25 00:20 ESTFinancialsCompany financials have been released.Neutral
2020-01-21 20:18 ESTEarningsEarnings have been released on November 3, 2016, with $0.49 earnings per share.Sell
2020-01-16 00:35 ESTFinancialsCompany financials have been released.Neutral
2020-01-14 04:05 ESTAnalyst RatingThe Analyst Target Price has increased from $119.08 to $119.69.Buy
2020-01-13 04:09 ESTAnalyst RatingThe Analyst Target Price has decreased from $119.38 to $119.08.Neutral
2020-01-09 04:03 ESTAnalyst RatingThe Analyst Target Price has increased from $119 to $119.38.Buy
2020-01-08 04:06 ESTAnalyst RatingThe Analyst Target Price has increased from $118.25 to $119.Buy
2020-01-06 04:04 ESTAnalyst RatingThe Analyst Target Price has increased from $117.33 to $118.25.Buy
2019-12-22 00:09 ESTFinancialsCompany financials have been released.Neutral
2019-12-17 00:23 ESTFinancialsCompany financials have been released.Neutral
2019-12-17 00:23 ESTAnalyst RatingThe Analyst Target Price has increased from $116.5 to $117.33.Buy
2019-11-29 00:10 ESTFinancialsCompany financials have been released.Neutral
2019-11-28 00:21 ESTFinancialsCompany financials have been released.Neutral
2019-11-27 03:54 ESTAnalyst RatingThe Analyst Target Price has increased from $114.58 to $116.5.Buy
2019-11-27 00:21 ESTFinancialsCompany financials have been released.Neutral
2019-11-22 00:06 ESTFinancialsCompany financials have been released.Neutral
2019-11-18 11:20 ESTNewsJ&J launches innovative study for expanded use of InvokanaN/A
2019-11-16 00:22 ESTFinancialsCompany financials have been released.Neutral
2019-11-14 00:00 ESTFinancialsCompany financials have been released.Neutral
2019-11-07 00:17 ESTFinancialsCompany financials have been released.Neutral
2019-10-31 15:49 ESTNewsPRA Health Sciences' (PRAH) CEO Colin Shannon on Q3 2019 Results - Earnings Call TranscriptN/A
2019-10-30 16:20 ESTNewsPRA Health Sciences EPS beats by $0.03, beats on revenueN/A

About PRA Health Sciences, Inc (PRAH):

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that clients to access and analyze Symphony Health and integrated third-party data. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.

See Advanced Chart

General

  • Name PRA Health Sciences, Inc
  • Symbol PRAH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Full Time Employees 17500
View More

Valuation

  • Trailing PE 22.05
  • Forward PE 13.81
  • Price/Sales (Trailing 12 Mt.)1.75
  • Price/Book (Most Recent Quarter) 4.74
  • Enterprise Value Revenue 2.08
  • Enterprise Value EBITDA 13.32
View More

Financials

  • Current Year EPS Estimate $5.19
  • Most Recent Quarter 2019-12-31
  • Profit Margin 0.08
  • Operating Margin 0.12
  • Return on Assets 0.07
  • Return on Equity 0.23
  • Revenue 3.07 billion
View More

Highlights

  • Market Capitalization 5.49 billion
  • EBITDA 481.72 million
  • PE Ratio 22.99
  • PEG Ratio 1.34
  • Analyst Target Price $107.77
  • Book Value $17.17 / share
  • Earnings Per Share $3.68
View More

Share Statistics

  • Shares Outstanding 63.63 million
  • Shares Float 63.39 million
  • % Held by Institutions 100%
  • Shares Short 1.76 million
  • Shares Short Ratio 3.12
  • Short % of Float 0.03%
  • Short % of Shares Outstanding 0.03%
View More

Technicals

  • Beta 1.08
  • 52 Week High $113.1
  • 52 Week Low $58.67
  • 50 Day Moving Average 86.26
  • 200 Day Moving Average 99.36
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
View More

PRA Health Sciences, Inc (PRAH) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

PRA Health Sciences, Inc (PRAH) Earnings Estimates:

An earnings estimate is an analyst's estimate for a company's future quarterly or annual earnings per share (EPS). Future earnings estimates are arguably the most important data when attempting to value a firm.

Date Number of Analysts Average Estimate Low Estimate High Estimate
2020-06-3011$1.43$1.35$1.51

PRA Health Sciences, Inc (PRAH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

PRAH's next estimated earnings release date is May 2, 2020.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2019-12-312020-02-20$800.24 million$1.54$1.474.76%
2019-09-302019-10-31$780.69 million$1.25$1.29-2.82%
2019-06-302019-08-01$763.31 million$0.62$1.18-47.8%
2019-03-312019-05-02$722.02 million$0.66$1.06-37.78%
2018-12-312019-02-28$729.65 million$1.07$1.27-15.5%
2018-09-302018-11-01$717.6 million$0.02$1.07-97.9%
2018-06-302018-08-02$722.84 million$0.64$0.96-33.82%
2018-03-312018-04-26$701.84 million$0.59$0.84-29.86%
2017-12-312018-02-22$655.9 million-$0.25$1.03-124.66%
2017-09-302017-10-26$582.01 million$0.73$0.85-13.91%
2017-06-302017-08-08$533.72 million$0.45$0.74-39.26%
2017-03-312017-04-26$487.76 million$0.39$0.60-35.75%
2016-12-312017-02-23$472.39 million$0.22$0.64-66.28%
2016-09-302016-11-03$453.26 million$0.49$0.64-23.84%
2016-06-302016-07-29$455.85 million$0.60$0.583.52%
2016-03-312016-04-28$430.22 million-$0.27
2015-12-312016-02-25$428.95 million$0.45
2015-09-302015-11-03$403.51 million$0.37
2015-06-302015-07-28$392.85 million$0.20
2015-03-312015-05-07$388.58 million$0.27
2014-12-312015-02-19$369.96 million-$0.45

PRA Health Sciences, Inc (PRAH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

PRA Health Sciences, Inc (PRAH) Chart:

PRA Health Sciences, Inc (PRAH) News:

Below you will find a list of latest news for PRA Health Sciences, Inc (PRAH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

PRA Health Sciences, Inc (PRAH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2020-04-17400CALL 227.85TRUE00
2020-04-17450CALL 196.09TRUE00
2020-04-17500CALL 167.67TRUE00
2020-04-17550CALL 141.91TRUE00
2020-04-17600CALL 118.28TRUE00
2020-04-17650CALL 96.37TRUE00
2020-04-17706.09CALL2 1095.58TRUE-0.3-0.05
2020-04-17758.4CALL1 384.95TRUE0.90.12
2020-04-17804.8CALL4 467.49TRUE-3.6-0.43
2020-04-17851.75CALL6 3261.21TRUE-0.83-0.32
2020-04-17901.6CALL1 262.98FALSE-0.35-0.18
2020-04-17951CALL5 240FALSE-5.3-0.84
2020-04-171000.7CALL1 480FALSE0.20.4
2020-04-171050.35CALL3 1870FALSE0.252.5
2020-04-171100.5CALL35 880FALSE-0.78-0.61
2020-04-171150.1CALL29 4584.79FALSE-0.1-0.5
2020-04-171202CALL1 2080FALSE0.10.05
2020-04-171250.45CALL1 520FALSE0.050.13
2020-04-171301.19CALL3 30FALSE1.190
2020-04-171350.25CALL2 20FALSE0.250
2020-04-171400CALL 0FALSE00
2020-04-171450CALL 0FALSE00
2020-04-17400PUT 0FALSE00
2020-04-17450PUT 0FALSE00
2020-04-17500.05PUT1 165.6FALSE0.050
2020-04-17550PUT 10FALSE00
2020-04-17603.7PUT1 210FALSE-0.05-0.01
2020-04-17651.45PUT1 20FALSE-0.9-0.38
2020-04-17703.2PUT46 560FALSE-1.6-0.33
2020-04-17756.6PUT10 110FALSE-0.63-0.09
2020-04-17800.01PUT4 1530.37FALSE-1.79-0.99
2020-04-17852PUT5 1972.28FALSE-6.92-0.78
2020-04-179015.8PUT2 6556.92TRUE-0.92-0.06
2020-04-179526.17PUT1 8761.65TRUE80.44
2020-04-1710021.68PUT62 3151.58TRUE13.481.64
2020-04-1710520PUT5 1543.52TRUE13.92.28
2020-04-171108.3PUT10 1954.99TRUE-1.4-0.14
2020-04-1711512.2PUT3 565.9TRUE3.20.36
2020-04-171200PUT 76.3TRUE00
2020-04-171250PUT 86.26TRUE00
2020-04-171300PUT 95.81TRUE00
2020-04-171350PUT 105TRUE00
2020-04-1714056PUT10 10113.85TRUE560
2020-04-171450PUT 122.38TRUE00
2020-05-15350CALL 143.95TRUE00
2020-05-15400CALL 137.91TRUE00
2020-05-154532.5CALL1 1119.21TRUE32.50
2020-05-15500CALL 113.01TRUE00
2020-05-155523CALL1 196.71TRUE230
2020-05-15600CALL 94.14TRUE00
2020-05-15650CALL 81.06TRUE00
2020-05-15700CALL 77.97TRUE00
2020-05-15750CALL 73.12TRUE00
2020-05-15806.17CALL1 368.29TRUE2.170.54
2020-05-15856.21CALL1 162.67TRUE3.711.48
2020-05-15900CALL 60.45FALSE00
2020-05-15953.87CALL1 55.02FALSE3.870
2020-05-151000CALL 57.7FALSE00
2020-05-151050CALL 62.33FALSE00
2020-05-151100CALL 64.63FALSE00
2020-05-151150CALL 0FALSE00
2020-05-15350PUT 0FALSE00
2020-05-15400PUT 0FALSE00
2020-05-15450PUT 0FALSE00
2020-05-15500PUT 0FALSE00
2020-05-15550PUT 113.03FALSE00
2020-05-15606.2PUT40 40125.28FALSE6.20
2020-05-15650PUT 88.41FALSE00
2020-05-15700PUT 76.25FALSE00
2020-05-15750PUT 65.05FALSE00
2020-05-15800PUT 57.61FALSE00
2020-05-15850PUT 55.93FALSE00
2020-05-15900PUT 54.17TRUE00
2020-05-15950PUT 59.06TRUE00
2020-05-151000PUT 56.8TRUE00
2020-05-151050PUT 56.51TRUE00
2020-05-151100PUT 56.49TRUE00
2020-05-151150PUT 61.87TRUE00
2020-07-17350CALL 99.55TRUE00
2020-07-17400CALL 93.24TRUE00
2020-07-17450CALL 88.5TRUE00
2020-07-17500CALL 81.47TRUE00
2020-07-17550CALL 77.13TRUE00
2020-07-17600CALL 72.73TRUE00
2020-07-17650CALL 68.14TRUE00
2020-07-177010.9CALL1 165.29TRUE10.90
2020-07-17750CALL 60.12TRUE00
2020-07-178011CALL1 959.39TRUE00
2020-07-178512.2CALL1 154.58TRUE3.90.47
2020-07-17904.4CALL11 1153.03FALSE-0.6-0.12
2020-07-17950.9CALL1 250.49FALSE-12.1-0.93
2020-07-171005.06CALL3 3248.07FALSE1.560.45
2020-07-171053.3CALL20 544.93FALSE1.20.57
2020-07-171101.92CALL1 2047.35FALSE-1.58-0.45
2020-07-171154.9CALL19 2048.2FALSE4.90
2020-07-171201.4CALL2 4143.58FALSE0.851.55
2020-07-171252.7CALL1 3753.18FALSE-1.5-0.36
2020-07-171300CALL 158.75FALSE00
2020-07-171350.75CALL2 40FALSE-0.7-0.48
2020-07-171400CALL 0FALSE00
2020-07-171450CALL 0FALSE00
2020-07-171500CALL 64.44FALSE00
2020-07-171550CALL 0FALSE00
2020-07-17350PUT 0FALSE00
2020-07-17400PUT 0FALSE00
2020-07-17450.56PUT1 1108.29FALSE0.560
2020-07-17500PUT 0FALSE00
2020-07-17555.2PUT9 90FALSE5.20
2020-07-17607.3PUT3 368.17FALSE1.80.33
2020-07-17650PUT 65.87FALSE00
2020-07-17705.1PUT27 2861.71FALSE-6.6-0.56
2020-07-17756.77PUT5 659.62FALSE0.220.03
2020-07-17800PUT 58.6FALSE00
2020-07-17857.35PUT21 2452.25FALSE-2.95-0.29
2020-07-179024.98PUT3 2153.35TRUE18.282.73
2020-07-17958.7PUT29 2953.35TRUE8.70
2020-07-171000PUT 53.62TRUE00
2020-07-1710530.9PUT1 2051.78TRUE4.40.17
2020-07-171100PUT 53.43TRUE00
2020-07-171150PUT 55.61TRUE00
2020-07-171200PUT 54.5TRUE00
2020-07-171250PUT 57.58TRUE00
2020-07-171300PUT 61.12TRUE00
2020-07-171350PUT 60.88TRUE00
2020-07-171400PUT 63.63TRUE00
2020-07-171450PUT 66.12TRUE00
2020-07-171500PUT 66.49TRUE00
2020-07-171550PUT 68.4TRUE00
2020-10-16350CALL 80.08TRUE00
2020-10-16400CALL 74.21TRUE00
2020-10-16450CALL 71.1TRUE00
2020-10-16500CALL 67.98TRUE00
2020-10-16550CALL 63.89TRUE00
2020-10-16600CALL 62.94TRUE00
2020-10-16650CALL 60.51TRUE00
2020-10-16700CALL 57.66TRUE00
2020-10-167511.9CALL6 656.84TRUE11.90
2020-10-16800CALL 54.57TRUE00
2020-10-16850CALL 51.97TRUE00
2020-10-16900CALL 49.58FALSE00
2020-10-16955.9CALL5 550.82FALSE5.90
2020-10-161000CALL 48.84FALSE00
2020-10-161050CALL 49.62FALSE00
2020-10-161100CALL 48.69FALSE00
2020-10-161150CALL 46.77FALSE00
2020-10-161200CALL 46.3FALSE00
2020-10-161250CALL 47.65FALSE00
2020-10-161300CALL 47.68FALSE00
2020-10-161350CALL 49.6FALSE00
2020-10-161400CALL 50.77FALSE00
2020-10-161450CALL 0FALSE00
2020-10-161500CALL 49.95FALSE00
2020-10-161550CALL 0FALSE00
2020-10-16350PUT 0FALSE00
2020-10-16400PUT 0FALSE00
2020-10-16454PUT52 320FALSE40
2020-10-16500PUT 68.03FALSE00
2020-10-16550PUT 65.36FALSE00
2020-10-16606.8PUT8 862.76FALSE6.80
2020-10-16650PUT 60.88FALSE00
2020-10-16700PUT 57.77FALSE00
2020-10-16750PUT 58.3FALSE00
2020-10-16800PUT 56.29FALSE00
2020-10-16850PUT 53.93FALSE00
2020-10-16900PUT 52.59TRUE00
2020-10-16950PUT 51.39TRUE00
2020-10-161000PUT 49.55TRUE00
2020-10-161050PUT 50.28TRUE00
2020-10-161100PUT 49.32TRUE00
2020-10-161150PUT 50.96TRUE00
2020-10-161200PUT 50.39TRUE00
2020-10-161250PUT 51.05TRUE00
2020-10-161300PUT 51.7TRUE00
2020-10-161350PUT 52.44TRUE00
2020-10-161400PUT 52.77TRUE00
2020-10-161450PUT 54.35TRUE00
2020-10-161500PUT 54.65TRUE00
2020-10-161550PUT 56.5TRUE00
2020-11-20350CALL 75.96TRUE00
2020-11-20400CALL 73.11TRUE00
2020-11-20450CALL 70.22TRUE00
2020-11-20500CALL 66.32TRUE00
2020-11-205527.6CALL5 63.44TRUE27.60
2020-11-206023.8CALL5 61.38TRUE-3.4-0.13
2020-11-20650CALL 60.02TRUE00
2020-11-207014.1CALL1 157.36TRUE14.10
2020-11-207514CALL1 156.15TRUE8.71.64
2020-11-20800CALL 52.35TRUE00
2020-11-20850CALL 51.54TRUE00
2020-11-209010.5CALL13 1951.76FALSE-1.35-0.11
2020-11-209510.6CALL4 449.59FALSE10.60
2020-11-201007.7CALL1 149.6FALSE7.70
2020-11-201050CALL 48.04FALSE00
2020-11-201107.8CALL1 1148.83FALSE0.30.04
2020-11-201154.23CALL423 35049.56FALSE4.230
2020-11-201208CALL1 146.54FALSE80
2020-11-201250CALL 48.26FALSE00
2020-11-201300CALL 46.96FALSE00
2020-11-201353.5CALL1 147.83FALSE3.50
2020-11-201400CALL 49.2FALSE00
2020-11-201452CALL2 248.96FALSE0.60.43
2020-11-201500CALL 51.86FALSE00
2020-11-201550CALL 50.68FALSE00
2020-11-201600.9CALL10 100FALSE0.90
2020-11-20350PUT 0FALSE00
2020-11-20400PUT 88.88FALSE00
2020-11-20450PUT 0FALSE00
2020-11-20500PUT 64.85FALSE00
2020-11-20550PUT 61.38FALSE00
2020-11-20606.76PUT1 160.59FALSE6.760
2020-11-20652.6PUT5 558.47FALSE1.41.17
2020-11-207012.4PUT1 256.92FALSE12.40
2020-11-20750PUT 55.5FALSE00
2020-11-208010.96PUT4 958.81FALSE-2.24-0.17
2020-11-208514.9PUT4 764.05FALSE-3.3-0.18
2020-11-20905.9PUT2 252.59TRUE-0.5-0.08
2020-11-20955.8PUT4 651.45TRUE00
2020-11-2010015.8PUT1 1152.5TRUE15.80
2020-11-2010519.2PUT2 250.24TRUE19.20
2020-11-2011030.52PUT1 152.19TRUE13.620.81
2020-11-201150PUT 51.84TRUE00
2020-11-2012037.1PUT5 51.87TRUE37.10
2020-11-201250PUT 52.82TRUE00
2020-11-201300PUT 53.14TRUE00
2020-11-2013553PUT5 52.77TRUE530
2020-11-201400PUT 54.71TRUE00
2020-11-201450PUT 54.88TRUE00
2020-11-201500PUT 55.27TRUE00
2020-11-201550PUT 57.17TRUE00
2020-11-201600PUT 57.42TRUE00

Latest PRAH Trades:

Date Shares Price
Apr 9, 2020 7:58 PM EST100$89.27
Apr 9, 2020 7:58 PM EST25$89.4
Apr 9, 2020 7:58 PM EST73$89.18
Apr 9, 2020 7:59 PM EST100$89.185
Apr 9, 2020 7:59 PM EST32$89.165

PRA Health Sciences, Inc (PRAH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2018-10-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1613859/000000000018033979/0000000000-18-033979-index.htm
2018-11-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1613859/000000000018034843/0000000000-18-034843-index.htm
2019-10-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000008025519002969/0000080255-19-002969-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000008025520001277/0000080255-20-001277-index.htm
2018-02-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000021545718004721/0000215457-18-004721-index.htm
2018-06-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000021545718005685/0000215457-18-005685-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000021545719005002/0000215457-19-005002-index.htm
2019-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000083423719000382/0000834237-19-000382-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000083423720002824/0000834237-20-002824-index.htm
2020-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000090221920000201/0000902219-20-000201-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000093247118004056/0000932471-18-004056-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000093247119006033/0000932471-19-006033-index.htm
2018-04-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1613859/000104746918003013/0001047469-18-003013-index.htm
2018-08-07424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746918005435/0001047469-18-005435-index.htm
2018-08-08424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746918005508/0001047469-18-005508-index.htm
2019-03-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1613859/000104746919000948/0001047469-19-000948-index.htm
2019-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1613859/000104746919002379/0001047469-19-002379-index.htm
2019-09-04424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746919004946/0001047469-19-004946-index.htm
2019-09-05424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746919005017/0001047469-19-005017-index.htm
2019-09-13424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746919005229/0001047469-19-005229-index.htm
2020-04-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1613859/000104746920002068/0001047469-20-002068-index.htm
2017-11-01S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1613859/000110465917065160/0001104659-17-065160-index.htm
2017-11-138-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465917067943/0001104659-17-067943-index.htm
2017-11-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465917069448/0001104659-17-069448-index.htm
2017-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465917074637/0001104659-17-074637-index.htm
2017-12-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465917075713/0001104659-17-075713-index.htm
2018-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm
2018-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm
2018-04-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918024903/0001104659-18-024903-index.htm
2018-04-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1613859/000110465918025621/0001104659-18-025621-index.htm
2018-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918026604/0001104659-18-026604-index.htm
2018-05-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918029351/0001104659-18-029351-index.htm
2018-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918029352/0001104659-18-029352-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918037085/0001104659-18-037085-index.htm
2018-05-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918037121/0001104659-18-037121-index.htm
2018-05-31S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918037123/0001104659-18-037123-index.htm
2018-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918038150/0001104659-18-038150-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918042047/0001104659-18-042047-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918042048/0001104659-18-042048-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918042049/0001104659-18-042049-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918042050/0001104659-18-042050-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918050976/0001104659-18-050976-index.htm
2018-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918052811/0001104659-18-052811-index.htm
2018-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918052812/0001104659-18-052812-index.htm
2018-11-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1613859/000110465918066242/0001104659-18-066242-index.htm
2019-04-18DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1613859/000110465919022339/0001104659-19-022339-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919034062/0001104659-19-034062-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919034064/0001104659-19-034064-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919034065/0001104659-19-034065-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919034066/0001104659-19-034066-index.htm
2019-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919046055/0001104659-19-046055-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919046966/0001104659-19-046966-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919046967/0001104659-19-046967-index.htm
2019-09-04FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919048481/0001104659-19-048481-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920017131/0001104659-20-017131-index.htm
2020-03-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920029723/0001104659-20-029723-index.htm
2020-04-03DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1613859/000110465920043152/0001104659-20-043152-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118007240/0001140361-18-007240-index.htm
2018-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118030961/0001140361-18-030961-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118030997/0001140361-18-030997-index.htm
2018-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118036243/0001140361-18-036243-index.htm
2018-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118036244/0001140361-18-036244-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000114036119003050/0001140361-19-003050-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036119016469/0001140361-19-016469-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036119016474/0001140361-19-016474-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000114036120003236/0001140361-20-003236-index.htm
2019-10-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000114420419047874/0001144204-19-047874-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000141057819001013/0001410578-19-001013-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000141057819001086/0001410578-19-001086-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000141057819001235/0001410578-19-001235-index.htm
2018-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000142284818000354/0001422848-18-000354-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000142284819000095/0001422848-19-000095-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000142284820000079/0001422848-20-000079-index.htm
2018-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385918000005/0001613859-18-000005-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385918000007/0001613859-18-000007-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000006/0001613859-19-000006-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1613859/000161385919000008/0001613859-19-000008-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000014/0001613859-19-000014-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385919000016/0001613859-19-000016-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000018/0001613859-19-000018-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000022/0001613859-19-000022-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385919000025/0001613859-19-000025-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000028/0001613859-19-000028-index.htm
2019-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385919000031/0001613859-19-000031-index.htm
2019-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000035/0001613859-19-000035-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000004/0001613859-20-000004-index.htm
2020-02-2110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1613859/000161385920000007/0001613859-20-000007-index.htm
2018-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000162828018001965/0001628280-18-001965-index.htm
2018-02-2210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1613859/000162828018002026/0001628280-18-002026-index.htm
2018-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000162828018004985/0001628280-18-004985-index.htm
2018-04-2610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000162828018005099/0001628280-18-005099-index.htm
2018-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000162828018010186/0001628280-18-010186-index.htm
2018-08-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000162828018010277/0001628280-18-010277-index.htm

PRA Health Sciences, Inc (PRAH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of PRA Health Sciences, Inc (PRAH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: < 1%
Institutional Ownership: 100%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2017-12-28David W DockhornExecutive Vice President & CCOSell4,236.0091.22386,407.920.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm
2018-01-16LINDA BADDOURExecutive VP & CFOSell2,595.0090.56235,003.200.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm
2017-11-16Matthew P. YoungDirectorSell5,115.0079.90408,688.500.00https://www.sec.gov/Archives/edgar/data/1613859/000110465917069448/0001104659-17-069448-index.htm
2018-06-21Jeffrey T BarberDirectorBuy1,307.0011,719.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918042048/0001104659-18-042048-index.htm
2019-06-03Jeffrey T BarberDirectorBuy1,436.0013,155.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919034062/0001104659-19-034062-index.htm
2019-08-13JAMES C MOMTAZEEDirectorBuy1,443.001,443.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919046055/0001104659-19-046055-index.htm
2018-06-21Alexander George DickinsonDirectorBuy1,307.002,397.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918042047/0001104659-18-042047-index.htm
2018-01-16LINDA BADDOURExecutive VP & CFOSell64,405.0090.265,813,195.302,595.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm
2019-08-13Michael J. BonelloEVP & CFOBuy9,000.0027,000.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919046967/0001104659-19-046967-index.htm
2019-09-06Fund Holdings L.P. KKR10% Share HolderSell6,666,684.0097.41649,401,688.4429,300.00https://www.sec.gov/Archives/edgar/data/1613859/000114036119016474/0001140361-19-016474-index.htm
2019-09-06PRA Investors L.P. KKR10% Share HolderSell6,666,684.0097.41649,401,688.4429,300.00https://www.sec.gov/Archives/edgar/data/1613859/000114036119016469/0001140361-19-016469-index.htm
2018-08-16COLIN SHANNONPresident & CEOBuy30,000.0030,000.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918052812/0001104659-18-052812-index.htm
2019-06-03Alexander George DickinsonDirectorBuy1,436.003,833.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919034064/0001104659-19-034064-index.htm
2018-06-21Matthew P. YoungDirectorBuy1,307.004,117.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918042050/0001104659-18-042050-index.htm
2017-12-28David W DockhornExecutive Vice President & CCOSell68,614.0090.816,230,837.344,236.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm
2019-06-03Matthew P. YoungDirectorBuy1,436.005,553.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919034065/0001104659-19-034065-index.htm
2019-08-13COLIN SHANNONPresident & CEOBuy33,000.0063,000.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919046966/0001104659-19-046966-index.htm
2018-06-21Linda S GraisDirectorBuy1,307.006,673.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918042049/0001104659-18-042049-index.htm
2018-08-09Fund Holdings L.P. KKR10% Share HolderSell6,500,000.00101.01656,565,000.006,695,984.00https://www.sec.gov/Archives/edgar/data/1613859/000114036118036244/0001140361-18-036244-index.htm
2018-08-09PRA Investors L.P. KKR10% Share HolderSell6,500,000.00101.01656,565,000.006,695,984.00https://www.sec.gov/Archives/edgar/data/1613859/000114036118036243/0001140361-18-036243-index.htm
2018-01-16LINDA BADDOURExecutive VP & CFOBuy67,000.0011.73785,910.0067,000.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm
2017-12-28David W DockhornExecutive Vice President & CCOBuy72,850.0011.73854,530.5072,850.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm
2019-06-03Linda S GraisDirectorBuy1,436.008,109.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919034066/0001104659-19-034066-index.htm